Bristol-Myers Squibb to Announce Results for Fourth Quarter 2017 on February 5th

Dec 19, 2017

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2017 on Monday, February 5, 2018. During a conference call at 8:00 a.m. ET on February 5th company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 866-548-4713 or international 323-794-2093, confirmation code: 4392051. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2018 through 11:00 a.m. ET on February 19, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820 confirmation code: 4392051.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.

Source: Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

Media:

Ken Dominski, 609-252-5251

ken.dominski@bms.com

or

Lisa McCormick Lavery, 609-252-7602

lisa.mccormicklavery@bms.com

or

Investors:

John Elicker, 609-252-4611

john.elicker@bms.com

or

Tim Power, 609-252-7509

timothy.power@bms.com

or

Bill Szablewski, 609-252-5894

william.szablewski@bms.com